XBiotech (XBIT)

• Market cap: $77.1M
• 1 day: -3.16%
• 5 days: 1.66%
• 1 month: -0.81%
• 3 months: -8.92%
• 6 months: -10.58%
• Year to date: -41.25%
• 1 year: -64.6%
• 5 years: -86.64%
• 10 years: -79.55%
• Sector: Healthcare
• Industry: Biotechnology

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 88